Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

153.70 -0.83 (-0.54%)
Streaming Delayed Price Updated: 12:06 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 335,501
Open 153.78
Bid (Size) 153.62 (1)
Ask (Size) 153.86 (2)
Prev. Close 154.53
Today's Range 153.02 - 155.02
52wk Range 92.14 - 183.00
Shares Outstanding 136,546,580
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
Via Benzinga
8 Analysts Have This To Say About Natera
Via Benzinga

Performance

YTD
-4.3%
-4.3%
1 Month
+8.1%
+8.1%
3 Month
-9.3%
-9.3%
6 Month
-5.2%
-5.2%
1 Year
+44.6%
+44.6%

More News

Read More
Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales
Via StockStory
Natera Reports First Quarter 2025 Financial Results
From Natera, Inc.
Via Business Wire
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress
From Natera, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Preview: Natera's Earnings
Via Benzinga
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows
From Natera, Inc.
Via Business Wire
What To Expect From Natera’s (NTRA) Q1 Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
From Natera, Inc.
Via Business Wire
Peering Into Natera's Recent Short Interest
Via Benzinga
Natera to Report its First Quarter Results on May 8, 2025
From Natera, Inc.
Via Business Wire
Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction
From Natera, Inc.
Via Business Wire
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
From Natera, Inc.
Via Business Wire
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
From Natera, Inc.
Via Business Wire
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Turn Down
Via StockStory
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
Via Benzinga
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Assessing Natera: Insights From 10 Financial Analysts
Via Benzinga
3 Reasons NTRA Has Explosive Upside Potential
Via StockStory
Topics Government Stocks
Exposures Political US Equities
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 153.70
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 05/21/25 12:06 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 20.99B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.